← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

▼ SELL 10b5-1 Plan

$ Value

$133K

Shares

266

Price

$500

Filed

Feb 18

Insider

Name

Bhatia Sangeeta N.

Title

CIK

0001643921

Roles

Director

Transaction Details

Transaction Date

2026-02-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,299

Footnotes

Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.

Filing Info

Accession No.

0000875320-26-000062

Form Type

4

Issuer CIK

0000875320

Bhatia Sangeeta N.'s History

Date Ticker Type Value
2026-02-13 VRTX $133K
2025-08-27 VRTX $103K
2025-05-02 VRTX $202K
2025-05-01 VRTX A $0

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-02-24
LEIDEN JEFFREY M
Executive Chairman
2026-02-24
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
$28.4M 2026-02-25
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-02-24
Biller Jonathan
EVP and Chief Legal Officer
$3.6M 2026-02-25
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
$1.6M 2026-02-25
Bozic Carmen
EVP and CMO
$2.2M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$2.0M 2026-02-26
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$2.5M 2026-02-25
McKechnie Duncan
EVP, Chief Commercial Officer
$2.4M 2026-02-25
Bunnage Mark E.
EVP, Chief Scientific Officer
$3.0M 2026-02-25